Cronos Group Inc. (CRON)
NASDAQ: CRON · Real-Time Price · USD
2.620
+0.070 (2.75%)
Oct 7, 2025, 4:00 PM EDT - Market closed
Cronos Group Market Cap
Cronos Group has a market cap or net worth of $997.07 million as of October 8, 2025. Its market cap has increased by 16.96% in one year.
Market Cap
997.07M
Enterprise Value
229.63M
1-Year Change
16.96%
Ranking
Category
Stock Price
$2.62
Market Cap Chart
Since February 27, 2018, Cronos Group's market cap has decreased from $1.14B to $997.07M, a decrease of -12.39%. That is a compound annual growth rate of -1.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2025 | 976.50M | 26.46% |
| Dec 31, 2024 | 772.20M | -3.05% |
| Dec 29, 2023 | 796.50M | -17.14% |
| Dec 30, 2022 | 961.30M | -34.04% |
| Dec 31, 2021 | 1.46B | -41.04% |
| Dec 31, 2020 | 2.47B | -6.25% |
| Dec 31, 2019 | 2.64B | 42.01% |
| Dec 31, 2018 | 1.86B | 63.14% |
| Feb 27, 2018 | 1.14B | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 753.98B |
| Johnson & Johnson | 454.31B |
| AbbVie | 413.22B |
| UnitedHealth Group | 326.22B |
| Novo Nordisk | 264.73B |
| AstraZeneca | 264.35B |
| Novartis AG | 256.18B |
| Abbott Laboratories | 234.25B |